Empowered Products, Inc., through its subsidiaries, engages in the development, bottling, and marketing of sexual wellness products. The company offers a line of topical gels, lotions, and oils that are formulated to increase mental focus and improve the bond of interpersonal relationships. It provides six products for men under the GUN OIL trademark and six products for women under the PINK trademark. Its products for men include GUN OIL Silicone, a silicone-based interactive lubricant; GUN OIL H2O, a water-based interactive lubricant; GUN OIL Force Recon, a water and silicone interactive lubricant; GUN OIL Gel, a gelatinous lubricant for men's personal toys; GUN OIL Stroke 29, a self-applied men's personal lubricant; and GUN OIL Jack Jelly, a self-applied men's personal lubricant in gelatinous form. The companys products for women comprise PINK Silicone, an interactive lubricant with silicone vitamin E and aloe vera; PINK Water, a water-based interactive lubricant with vitamin E and aloe vera; Hot PINK, an exothermic massage lubricant; PINK Frolic, a women's personal toy lubricant; PINK Unity, a gelatinous hybrid lubricant with silicone and water; and PINK Indulgence Crme, a massage lubricant in a cream format. It also offers orally-administered nutritional supplements, which are herbal-based formulas related to sexual performance and desire.
The company provides its nutritional supplements under the PINK Elevate Libido and PINK Elevate Performance brand names for women; and under the GUN OIL High Caliber Drive and GUN OIL High Caliber Performance brand names for men. It contracts with independent third-party companies to mix its topical gels, lotions, and oils. The company markets its products through a network of distributors, wholesalers, pharmacies, and chain and online retailers in North America, Europe, and Asia; and sells directly to retail consumers through its online store. Empowered Products, Inc. is headquartered in Las Vegas, Nevada.
BSD MEDICAL CORPORATION (NASDAQ: BSDM) "Up 66.10% in morning trading"
BSD Medical Corporation develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused radiofrequency (RF) and microwave energy. BSDs product lines include both hyperthermia and ablation treatment systems. BSDs hyperthermia cancer treatment systems, which have been in use for several years in the United States, Europe and Asia, are used to treat certain tumors with heat (hyperthermia) while increasing the effectiveness of other therapies such as radiation therapy. BSDs microwave ablation system has been developed as a stand-alone therapy to ablate and destroy soft tissue. The Company has developed extensive intellectual property, multiple products in the market and well established distribution in the United States, Europe and Asia. Certain of the Companys products have received regulatory approvals in the United States, Europe and China.
ATTITUDE DRINKS INCORPORATED (OTCBB: ATTD) "Up 10.00% in morning trading"
Attitude Drinks Inc. is an innovative, beverage brand development company with a focus on functional milk, ready-to-drink beverages. Phase III Recovery Drink is the company's first, functional milk drink exploiting recent scientific evidence of the benefits of milk and protein as an exercise recovery aid. The February 2010 launch of Phase III marks the first time a sports drink has been formulated from real milk.
ONCOSEC MEDICAL INCORPORATED (OTCBB: ONCS) "Up 19.23% in morning trading"
OncoSec Medical Incorporated is a biopharmaceutical company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers. ImmunoPulse and NeoPulse therapies address an unmet medical need and represent a potential solution, for less invasive and less expensive therapies that are able to minimize detrimental effects resulting from currently available cancer treatments such as surgery, systemic chemotherapy or immunotherapy and other treatment alternatives. OncoSec's core technology is based upon its proprietary use of an electroporation platform to dramatically enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of various solid cancers using these powerful and targeted anti-cancer agents has demonstrated selective destruction of cancerous cells while sparing healthy normal tissues during early and late stage clinical trials. OncoSec's clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers.
OTCPicks.com, one of the leading penny stock Web sites, presents its daily Stocks to Watch and Midday Market Movers every weekday. In addition to all the latest penny stock news, OTCPicks also offers daily newsletters, unique commentaries and free profiles, alerts and investing tips.
The stocks presented above are available in OTCPicks.com's Free Daily Email Newsletter. For daily stock alerts go to http://www.otcpicks.com to sign up.
Disclosure: OTCPicks.com and affiliates have been compensated Four Thousand Five Hundred dollars by a unaffiliated third party (Crown Pacifica) for promotional coverage of EMPO.